Douglas Arenberg
Cited by
Cited by
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
RM Strieter, PJ Polverini, SL Kunkel, DA Arenberg, MD Burdick, J Kasper, ...
Journal of Biological Chemistry 270 (45), 27348-27357, 1995
CXC chemokines in angiogenesis
JA Belperio, MP Keane, DA Arenberg, CL Addison, JE Ehlert, MD Burdick, ...
Journal of leukocyte biology 68 (1), 1-8, 2000
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
DA Arenberg, SL Kunkel, PJ Polverini, M Glass, MD Burdick, RM Strieter
The Journal of clinical investigation 97 (12), 2792-2802, 1996
The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis.
MP Keane, DA Arenberg, JP Lynch, RI Whyte, MD Iannettoni, MD Burdick, ...
The Journal of Immunology 159 (3), 1437-1443, 1997
Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines
N Ramnath, TJ Dilling, LJ Harris, AW Kim, GC Michaud, AA Balekian, ...
Chest 143 (5), e314S-e340S, 2013
Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.
DA Arenberg, SL Kunkel, PJ Polverini, SB Morris, MD Burdick, MC Glass, ...
The Journal of experimental medicine 184 (3), 981-992, 1996
Interferon γ-inducible protein-10 (IP-10), a member of the CXC chemokine family, is an inhibitor of angiogenesis
RM Strieter, SL Kunkel, DA Arenberg, MD Burdick, PJ Polverini
Biochemical and biophysical research communications 210 (1), 51-57, 1995
Final toxicity results of a radiation-dose escalation study in patients with non–small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis
FM Kong, JA Hayman, KA Griffith, GP Kalemkerian, D Arenberg, S Lyons, ...
International Journal of Radiation Oncology* Biology* Physics 65 (4), 1075-1086, 2006
Differential protein expression profiling by iTRAQ− 2DLC− MS/MS of lung Cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype
VG Keshamouni, G Michailidis, CS Grasso, S Anthwal, JR Strahler, ...
Journal of proteome research 5 (5), 1143-1154, 2006
Role of C‐X‐C chemokines as regulators of angiogenesis in lung cancer
RM Strieter, PJ Polverini, DA Arenberg, A Walz, G Opdenakker, ...
Journal of leukocyte biology 57 (5), 752-762, 1995
The role of CXC chemokines as regulators of angiogenesis.
RM Strieter, PJ Polverini, DA Arenberg, SL Kunkel
Shock (Augusta, Ga.) 4 (3), 155-160, 1995
IFN-γ-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis
MP Keane, JA Belperio, DA Arenberg, MD Burdick, ZJ Xu, YY Xue, ...
The journal of immunology 163 (10), 5686-5692, 1999
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.
DA Arenberg, MP Keane, B DiGiovine, SL Kunkel, SB Morris, YY Xue, ...
The Journal of clinical investigation 102 (3), 465-472, 1998
Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis
MP Keane, JA Belperio, TA Moore, BB Moore, DA Arenberg, RE Smith, ...
The Journal of Immunology 162 (9), 5511-5518, 1999
Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8.
B DiGiovine, JP Lynch, FJ Martinez, A Flint, RI Whyte, MD Iannettoni, ...
The Journal of Immunology 157 (9), 4194-4202, 1996
Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer
VG Keshamouni, RC Reddy, DA Arenberg, B Joel, VJ Thannickal, ...
Oncogene 23 (1), 100-108, 2004
Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells
BB Moore, DA Arenberg, K Stoy, T Morgan, CL Addison, SB Morris, ...
The American journal of pathology 154 (5), 1503-1512, 1999
The role of CXC chemokines in the regulation of angiogenesis in non‐small cell lung cancer
DA Arenberg, PJ Polverini, SL Kunkel, A Shanafelt, J Hesselgesser, ...
Journal of Leukocyte Biology 62 (5), 554-562, 1997
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis
ES White, KR Flaherty, S Carskadon, A Brant, MD Iannettoni, J Yee, ...
Clinical Cancer Research 9 (2), 853-860, 2003
Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma: The impact of tumor‐associated macrophages
B Marcus, D Arenberg, J Lee, C Kleer, DB Chepeha, CE Schmalbach, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
The system can't perform the operation now. Try again later.
Articles 1–20